The NIH’s Independent Test Assessment Program plans to establish an accelerated pathway to help the FDA find test manufacturers that can make their tests at a significant scale. The NIH said the goal is to accelerate the availability of more high-quality, accurate over-the-counter tests to the public as quickly as possible.
“Access to easy-to-use, affordable and reliable COVID tests is key to bringing peace of mind to our families, especially as we approach winter,” HHS Secretary Xavier Becerra said in a news release.
The NIH program aims to increase over-the-counter testing options to increase overall supply and potentially lower testing costs.
The FDA also said that it has authorized the 10th over-the-counter COVID-19 test, a rapid antigen test called DiaTrust, made by Celltrion.
Read the full news release here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
